Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Arruda

Showing results (11-20 of 185) with videos related to

Pageof 19
Sort By:
Human Molecular Genetics|October 10, 2019
Gene therapy matures to medicinesBeverly L Davidson, Valder R Arruda
Expert Review of Cardiovascular Therapy|March 20, 2004
Update on gene therapy for hereditary hematological disordersRoland W Herzog, Volder R Arruda
Neuromuscular Disorders : NMD|March 28, 2008
Substantial immune suppression required in gene therapy for muscular dystrophy?Roland W Herzog, Valder R Arruda
Thrombosis Research|June 12, 2012
The protein C pathway in cancer metastasisC Arnold Spek, Valder R Arruda
Journal of Genetic Syndromes & Gene Therapy|June 3, 2014
Muscle Gene Therapy for HemophiliaDenise E Sabatino, Valder R Arruda
Mediterranean Journal of Hematology and Infectious Diseases|September 21, 2020
Gene Therapy for Hemophilia: Facts and Quandaries in the 21st CenturyValder R Arruda, Bhavya S Doshi
Molecular Therapy. Methods & Clinical Development|February 2, 2019
Protein-Engineered Coagulation Factors for Hemophilia Gene TherapyBenjamin J Samelson-Jones, Valder R Arruda
Frontiers in Immunology|May 20, 2020
Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia ABenjamin J Samelson-Jones, Valder R Arruda
Journal of Thrombosis and Haemostasis : JTH|April 11, 2016
Gene therapy for immune tolerance induction in hemophilia with inhibitorsV R Arruda, B J Samelson-Jones
Annals of Hematology|October 1, 1996
High-dose dexamethasone therapy in chronic idiopathic thrombocytopenic purpuraV R Arruda, J M Annichino-Bizzacchi
Pageof 19

Showing results (11-20 of 185) with videos related to

Sort By:
Pageof 19
Human Molecular Genetics|October 10, 2019
Gene therapy matures to medicinesBeverly L Davidson, Valder R Arruda
Expert Review of Cardiovascular Therapy|March 20, 2004
Update on gene therapy for hereditary hematological disordersRoland W Herzog, Volder R Arruda
Neuromuscular Disorders : NMD|March 28, 2008
Substantial immune suppression required in gene therapy for muscular dystrophy?Roland W Herzog, Valder R Arruda
Thrombosis Research|June 12, 2012
The protein C pathway in cancer metastasisC Arnold Spek, Valder R Arruda
Journal of Genetic Syndromes & Gene Therapy|June 3, 2014
Muscle Gene Therapy for HemophiliaDenise E Sabatino, Valder R Arruda
Mediterranean Journal of Hematology and Infectious Diseases|September 21, 2020
Gene Therapy for Hemophilia: Facts and Quandaries in the 21st CenturyValder R Arruda, Bhavya S Doshi
Molecular Therapy. Methods & Clinical Development|February 2, 2019
Protein-Engineered Coagulation Factors for Hemophilia Gene TherapyBenjamin J Samelson-Jones, Valder R Arruda
Frontiers in Immunology|May 20, 2020
Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia ABenjamin J Samelson-Jones, Valder R Arruda
Journal of Thrombosis and Haemostasis : JTH|April 11, 2016
Gene therapy for immune tolerance induction in hemophilia with inhibitorsV R Arruda, B J Samelson-Jones
Annals of Hematology|October 1, 1996
High-dose dexamethasone therapy in chronic idiopathic thrombocytopenic purpuraV R Arruda, J M Annichino-Bizzacchi
Pageof 19